A new latex agglutination (LA) test (Wampole Laboratories, Cranbury, N.J.) 
A new latex agglutination (LA) test (Wampole Laboratories, Cranbury, N.J.) for detection of antibody to herpes simplex virus was compared with a reference complement fixation (CF) method in a premarket evaluation. Of 102 serum samples tested, 19 were LA negative and CF negative, 79 were LA positive and CF positive, and 4 were LA positive and CF negative. An The LA kit included latex reagent sensitized with HSV antigen, a buffered diluent, positive and negative controls, and reusable glass slides. According to the manufacturer, the LA kit detects immunoglobulin G and M to both HSV type 1 (HSV-1) and HSV-2, but does not provide type-specific antibody determination. Serum dilutions were prepared in microtiter plates, and 25-,ul samples were placed on glass slides and mixed with 15 ,ul of latex reagent with the aid of disposable stirrers. The slides were placed under humidifying covers, rotated on a mechanical rotator for 10 min at 100 rpm, and then immediately observed for agglutination under incandescent light projected obliquely. Agglutination was defined as distinct large clumps against a clear or slightly cloudy background or small but definite clumps against a cloudy background. Positive and negative controls were tested with each run. All serum samples were titrated to endpoint. Specimens with titers Qf .4 were considered positive by LA.
Testing by EIA was performed and interpreted according to the manufacturer's instructions. Serum samples with values of -1 were considered positive by EIA. Positive and negative controls were tested with each patient run.
Of 102 serum samples tested, 23 (22.5%) were negative for antibody to HSV by CF, and 79 (77.5%) had CF titers ranging from 4 to 256. Of 10 patients with paired sera, 1 showed a fourfold increase in CF titers (16 to 64).
The LA method yielded 19 (19%) negative and 83 (81%) EIA testing was also performed on seven serum samples which were positive by LA and had borderline-positive CF titers of 4. Low levels of antibody to HSV were detected by EIA in six of the seven samples. There was a single borderline-negative specimen which showed weak agglutination by LA at a 1:2 dilution and was negative also by CF and EIA.
When LA titers were compared with CF titers for the 79 LA-positive, CF-positive specimens, no linear correlation was found. However, for 74 samples (94% of all specimens positive with both CF and LA) the LA titers were higher than the CF titers. Most specimens (85%) had LA titers two to four doubling dilutions higher than CF titers (Fig. 1) .
As all serum samples which were positive by CF at titers of -4 or by EIA had LA titers of .4, we recommend diluting the serum 1:4 for LA screening. In view of the prozone effect observed in 2.5% of the positive serum samples, it is advisable to add a second serum dilution for routine screening to insure detection of all sera with high antibody titers. Given the distribution of the LA titers and their general correlation to CF titers, routine screening of 1:4 and 1:64 serum dilutions seems appropriate and would provide semiquantitative results which should suffice for most patients. If a more precise semiquantitation were desired, a third dilution (1:256) could be added. Titration to endpoint is also easily performed with the LA method by testing doubling serum dilutions prepared in microdilution plates. This more expensive test format should be reserved for selected patients in whom determination of precise antibody titers to HSV is deemed clinically useful. We conclude that this new LA kit for HSV serology offers a sensitive, simple, and rapid alternative method for detection of immunoglobulin G to HSV, without the need for expensive equipment or special technical expertise.
We thank Wampole Laboratories for providing support for this study.
